The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
January 29th 2025
This marks the first US biologic license application filing acceptance for a biosimilar candidate to golimumab.
Combination Pill Improves Adherence in Cardiovascular Disease Patients
September 5th 2013Patients with or at high risk for cardiovascular disease who took a pill that combined aspirin, a statin, and 2 antihypertensives had significantly higher adherence levels than those who received usual care.
Read More